about
Medical and surgical treatment for ocular myastheniaMedical and surgical treatment for ocular myastheniaMedical and surgical treatment for ocular myastheniaQuality of life in purely ocular myasthenia in Japan.Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.Surgical treatment for medically refractory myasthenic blepharoptosis.Quantitative motor assessment of muscular weakness in myasthenia gravis: a pilot study.Myasthenia gravis: clinical, immunological, and therapeutic advances.Factors influencing the outcome of transsternal thymectomy for myasthenia gravis.Clinical aspects of neuromuscular transmission disorders.Treatment strategies for myasthenia gravis.Heat-shock proteins in clinical neurology.Serum levels of matrix metalloproteinases: implications in clinical neurology.Glucocorticoids in myasthenia gravis - if, when, how, and how much?Matrix metalloproteinase-3 in myasthenia gravis compared to other neurological disorders and healthy controls.Is Surgical Intervention Safe and Effective in the Treatment of Myasthenic Blepharoptosis? A Multicenter Survey in JapanAnti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis
P2860
Q24202289-1DAA305F-60C3-4CE2-A3F3-EDFF13ACA0D0Q24245255-F2C5C22F-D341-4713-AD5F-A1401A2EC19FQ24246392-F750E918-EF4B-4963-B43A-863DA5956C13Q33869796-3DED0FC2-8BA1-4347-BC4E-3627C0987A7FQ34043022-B647E873-0E0B-4EAD-9A5E-3A4E95901F6AQ34265890-D03B2A07-8CF2-4D40-BBDC-200E720E379FQ35877852-474D6DAD-1E54-4608-A3AB-2CAF758FD18FQ36006116-4B0C3382-53DE-41B2-83C5-AB8FC746E963Q36189264-3218689C-18DE-47D3-9556-DFF0AA4035E7Q36459479-35F6C254-36E3-4D27-9105-7EC37D98FD78Q37483922-A2B2C671-51A5-4334-982B-571752CF7462Q37901289-2D24688E-8939-4CF2-859C-E12FE029A9D9Q37977361-5FDFF7C6-15E4-4BC8-9D52-77DCF9361756Q38234725-50490896-DE2D-451A-B5B3-9078B4900B33Q42855120-17B933D7-4A9D-49D7-8CEA-867899778965Q58047406-878E2D82-1614-4434-BFD6-B8225DAE03CCQ58047456-8B1FF29F-627E-4B3F-A570-685F45436839
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Therapeutic options in ocular myasthenia gravis.
@ast
Therapeutic options in ocular myasthenia gravis.
@en
Therapeutic options in ocular myasthenia gravis.
@nl
type
label
Therapeutic options in ocular myasthenia gravis.
@ast
Therapeutic options in ocular myasthenia gravis.
@en
Therapeutic options in ocular myasthenia gravis.
@nl
prefLabel
Therapeutic options in ocular myasthenia gravis.
@ast
Therapeutic options in ocular myasthenia gravis.
@en
Therapeutic options in ocular myasthenia gravis.
@nl
P2093
P1476
Therapeutic options in ocular myasthenia gravis.
@en
P2093
P304
P356
10.1016/S0960-8966(00)00173-5
P577
2001-03-01T00:00:00Z